(Reuters) -Swiss lender UBS is in talks to sell its hedge fund unit, O'Connor, to U.S. brokerage Cantor Fitzgerald, Bloomberg ...

UBS Group (NYSE:UBS) is in discussions to sell its O'Connor hedge fund unit to Cantor Fitzgerald. A potential deal may ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been ...

UBS Group is in talks to sell its hedge fund unit O’Connor to Cantor Fitzgerald, according to people familiar with the matter ...

UBS Group AG is in talks to sell its hedge fund unit O’Connor to Cantor Fitzgerald LP, a move that would end a more than three-decade run of ownership by the Swiss bank, according to people familiar ...

Backed by Tether and SoftBank, Twenty One Capital is coming for Strategy's crypto crown -- and it's not playing small.

When Michael Saylor transformed his long-fading software firm into a Bitcoin juggernaut in 2020, he pulled off one of the ...

Cantor Fitzgerald, SoftBank, Tether, and Bitfinex have joined hands to launch a public Bitcoin company with the ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

Technology to Neutral from Overweight in a note Wednesday, citing growing concerns over the company’s future custom silicon business and key client defections.

Brandon Lutnick, son of U.S. Commerce Secretary Howard Lutnick and chair of brokerage Cantor Fitzgerald, revealed a multi-billion-dollar acquisition vehicle backed by crypto giants. The brokerage firm ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...